We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
QARZIBA dinutuximab beta 4.5 mg/mL concentrate for solution for infusion, 20 mg/4.5 mL vial (321016)
ARTG ID 321016
ARTG Name
QARZIBA dinutuximab beta 4.5 mg/mL concentrate for solution for infusion, 20 mg/4.5 mL vial
Product name
QARZIBA dinutuximab beta 4.5 mg/mL concentrate for solution for infusion, 20 mg/4.5 mL vial
ARTG Date
Registration Type
Medicine
Therapeutic good type
Medicine
Ingredients
dinutuximab beta
Licence category
RE
Licence status
A
Summary
Product information
Consumer medicine information